Page last updated: 2024-08-23

raloxifene hydrochloride and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol

raloxifene hydrochloride has been researched along with 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kumar, P; Song, ZH	1

Other Studies

1 other study(ies) available for raloxifene hydrochloride and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol

Article	Year
Identification of raloxifene as a novel CB2 inverse agonist. Biochemical and biophysical research communications, 2013, May-24, Volume: 435, Issue:1 Topics: Benzoxazines; Binding, Competitive; Bone Density Conservation Agents; Colforsin; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Drug Approval; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Morpholines; Naphthalenes; Raloxifene Hydrochloride; Receptor, Cannabinoid, CB2; Transfection; Tritium; United States; United States Food and Drug Administration	2013

Article

Year

Identification of raloxifene as a novel CB2 inverse agonist.

Biochemical and biophysical research communications, 2013, May-24, Volume: 435, Issue:1

Topics: Benzoxazines; Binding, Competitive; Bone Density Conservation Agents; Colforsin; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Drug Approval; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Morpholines; Naphthalenes; Raloxifene Hydrochloride; Receptor, Cannabinoid, CB2; Transfection; Tritium; United States; United States Food and Drug Administration

2013